EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kappa‐Free Light Chain Index in Late‐Onset Multiple Sclerosis

Domizia Vecchio, Eleonora Virgilio, Paola Cavalla, Chiara Puricelli, Valentina Ciampana, Loredana Paciolla, Angelo Bianchi, Claudia Norese, Alessandro Franceschini, Chiara Bosa, Marco Capobianco, Umberto Dianzani und 3 weitere

Acta Neurologica Scandinavica · 2026-01 · 2026 (1)

DOI: 10.1155/ane/2433357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 14.11.2026. Verfasst von Domizia Vecchio und 14 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Late‐onset multiple sclerosis (LOMS) remains less characterized in terms of clinical phenotypes, biomarkers, and outcomes compared to adult‐onset MS (AOMS).

Objectives

This multicentric study is first aimed at comparing biomarkers of intrathecal synthesis between the two groups. Secondly, we characterized the clinical and radiological longitudinal features in a subgroup of LOMS.

Methods

We included 530 bout‐onset MS cases (70 LOMS) undergoing cerebrospinal fluid analysis to evaluate the link and kappa indexes and oligoclonal bands (OCBs). The clinical–longitudinal analysis was performed in 215 patients (28 LOMS) tested for lambda‐free light chains, with data collected on onset type, baseline magnetic resonance imaging, disability at diagnosis, and last follow‐up.

Results

Established biomarkers of intrathecal synthesis (OCB and link index) did not differ among groups, whereas the kappa index was lower in LOMS (median [interquartile range]: 24.4 [59.4]) compared to AOMS (34.1 [66.9]; p = 0.03), with no difference in serum creatinine. In the subgroup analysis, LOMS presented more frequently with brainstem, cerebellar, spinal, or multifocal symptoms, despite no differences in radiological findings or disability. Both populations had similar exposure to treatments.

Conclusions

The kappa index emerged as the only biomarker of intrathecal synthesis that significantly differed in bout‐onset LOMS, being lower than in AOMS. Larger cohort studies are needed to elucidate these findings.

Zitieren

APA

Vecchio, D., Virgilio, E., Cavalla, P., Puricelli, C., Ciampana, V., Paciolla, L., Bianchi, A., Norese, C., Franceschini, A., Bosa, C., Capobianco, M., Dianzani, U., Ferrandi, D., Comi, C., & Vercellino, M. (2026). Kappa‐Free Light Chain Index in Late‐Onset Multiple Sclerosis. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/2433357

Vancouver

Vecchio D, Virgilio E, Cavalla P, Puricelli C, Ciampana V, Paciolla L, et al. Kappa‐Free Light Chain Index in Late‐Onset Multiple Sclerosis. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/2433357

BibTeX
@article{Vecchio2026,
  author = {Vecchio, Domizia and Virgilio, Eleonora and Cavalla, Paola and Puricelli, Chiara and Ciampana, Valentina and Paciolla, Loredana and Bianchi, Angelo and Norese, Claudia and Franceschini, Alessandro and Bosa, Chiara and Capobianco, Marco and Dianzani, Umberto and Ferrandi, Delfina and Comi, Cristoforo and Vercellino, Marco},
  title = {Kappa‐Free Light Chain Index in Late‐Onset Multiple Sclerosis},
  journal = {Acta Neurologica Scandinavica},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ane/2433357}
}
Kostenlos starten →